Circulating cell-free DNA as a predictive marker for distant metastasis of hepatitis C virus-related hepatocellular carcinoma

British Journal of Cancer

Volumn 97, Issue 10, 2007, Pages 1399-1403

  Tokuhisa, Y ^a   Iizuka, N ^a   Sakaida, I ^a   Moribe, T ^b   Fujita, N ^b   Miura, T ^b   Tamatsukuri, S ^b   Ishitsuka, H ^b   Uchida, K ^a   Terai, S ^a   Sakamoto, K ^a   Tamesa, T ^a   Oka, M ^a  

^a YAMAGUCHI UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Molecular Diagnostics Division   (Japan)

Author keywords

Blood testing; Cell free DNA; GSTP1; HCC; HCV; Real time PCR

Indexed keywords

DNA; TUMOR MARKER;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CANCER PATIENT; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; HEPATITIS C VIRUS; HUMAN; LIVER CELL CARCINOMA; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; METASTASIS; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; SURVIVAL TIME; TREATMENT OUTCOME; VIRUS CARCINOGENESIS; VIRUS CARRIER;

AGED; CARCINOMA, HEPATOCELLULAR; DNA, NEOPLASM; FEMALE; FOLLOW-UP STUDIES; HEPACIVIRUS; HEPATITIS C; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; RECURRENCE; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 36148975739     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6604034     Document Type: Article

References (28)

1. Anker P, Mulcahy H, Chen XQ, Stroun M (1999) Detection of circulating tumour DNA in the blood (plasma/serum) of cancer patients. Cancer Metastasis Rev 18: 65-73
2. Deuffic S, Poynard T, Buffat L, Valleron AJ (1998) Trends in primary liver cancer. Lancet 351: 214-215
3. El Serag HB (2004) Hepatocellular carcinoma: recent trends in the United States. Gastroenterology 127: S27-S34
4. Gautschi O, Bigosch C, Huegli B, Jermann M, Marx A, Chasse E, Ratschiller D, Weder W, Joerger M, Betticher DC, Stahel RA, Ziegler A (2004) Circulating deoxyribonucleic acid as prognostic marker in non-small-cell lung cancer patients undergoing chemotherapy. J Clin Oncol 22: 4157-4164
5. Iizuka N, Hamamoto Y, Oka M (2004) Predicting individual outcomes in hepatocellular carcinoma. Lancet 364: 1837-1839
6. Iizuka N, Oka M, Okabe H, Nishida M, Maeda Y, Mori N, Takao T, Tamesa T, Tangoku A, Tabuchi H, Hamada K, Nakayama H, Ishitsuka H, Miyamoto T, Hirabayashi A, Uchimura S, Hamamoto Y (2003) Oligonucleotide microarray for prediction of early intrahepatic recurrence of hepatocellular carcinoma after curative resection. Lancet 361: 923-929
7. Iizuka N, Oka M, Yamada-Okabe H, Mori N, Tamesa T, Okada T, Takemoto N, Tangoku T, Hamada K, Nakayama H, Miyamoto T, Uchimura S, Hamamoto Y (2002) Comparison of gene expression profiles between hepatitis B virus- and hepatitis C virus-infected hepatocellular carcinoma by oligonucleotide microarray data on the basis of a supervised learning method. Cancer Res 62: 3939-3944
8. Iizuka N, Sakaida I, Moribe T, Fujita N, Miura T, Stark M, Tamatsukuri S, Ishitsuka H, Uchida K, Terai S, Sakamoto K, Tamesa T, Oka M (2006a) Elevated levels of circulating cell-free DNA in the blood of patients with hepatitis C virus-associated hepatocellular carcinoma. Anticancer Res 26: 4713-4719
9. Iizuka N, Tamesa T, Sakamoto K, Miyamoto T, Hamamoto Y, Oka M (2006b) Different molecular pathways determining extrahepatic and intrahepatic recurrences of hepatocellular carcinoma. Oncol Rep 16: 1137-1142
10. Itoh Y, Ohkubo K, Iuchi H, Michitaka K, Horiike N, Onji M (2002) Chronological changes of causes of death and distant metastasis in hepatocellular carcinoma. Oncol Rep 9: 331-335
11. Kumada T, Nakano S, Takeda I, Sugiyama K, Osada T, Kiriyama S, Sone Y, Toyoda H, Shimada S, Takahashi M, Sassa T (1997) Patterns of recurrence after initial treatment in patients with small hepatocellular carcinoma. Hepatology 25: 87-92
12. Kuramitsu Y, Nakamura K (2006) Proteomic analysis of cancer tissues: shedding light on carcinogenesis and possible biomarkers. Proteomics 6: 5650-5661
13. Kurokawa Y, Matoba R, Takemasa I, Nagano H, Dono K, Nakamori S, Umeshita K, Sakon M, Ueno N, Oba S, Ishii S, Kato K, Monden M (2004) Molecular-based prediction of early recurrence in hepatocellular carcinoma. J Hepatol 41: 284-291
14. Leon SA, Shapiro B, Sklaroff DM, Yaros MJ (1977) Free DNA in the serum of cancer patients and the effect of therapy. Cancer Res 37: 646-650
15. Llovet JM, Burroughs A, Bruix J (2003) Hepatocellular carcinoma. Lancet 362: 1907-1917
16. Mann CD, Neal CP, Garcea G, Manson MM, Dennison AR, Berry DP (2007) Prognostic molecular markers in hepatocellular carcinoma: a systematic review. Eur J Cancer 43: 979-992
17. Marrero JA, Lok AS (2004) Newer markers for hepatocellular carcinoma. Gastroenterology 127: S113-S119
18. Matoba K, Iizuka N, Gondo T, Ishihara T, Yamada-Okabe H, Tamesa T, Takemoto N, Hashimoto K, Sakamoto K, Miyamoto T, Uchimura S, Hamamoto Y, Oka M (2005) Tumor HLA-DR expression linked to early intrahepatic recurrence of hepatocellular carcinoma. Int J Cancer 115: 231-240
19. Nart D, Arikan C, Akyildiz M, Yuce G, Demirpolat G, Zeytunlu M, Karasu Z, Aydogdu S, Killi R, Yuzer Y, Tokat Y, Kilic M (2003) Hepatocellular carcinoma in liver transplant era: a clinicopathologic analysis. Transplant Proc 35: 2986-2990
20. Parkin DM, Bray F, Ferlay J, Pisani P (2001) Estimating the world cancer burden: Globocan 2000. Int J Cancer 94: 153-156
21. Portolani N, Coniglio A, Ghidoni S, Giovanelli M, Benetti A, Tiberio GA, Giulini SM (2006) Early and late recurrence after liver resection for hepatocellular carcinoma: prognostic and therapeutic implications. Ann Surg 243: 229-235
22. Ren N, Qin LX, Tu H, Liu YK, Zhang BH, Tang ZY (2006) The prognostic value of circulating plasma DNA level and its allelic imbalance on chromosome 8p in patients with hepatocellular carcinoma. J Cancer Res Clin Oncol 132: 399-407
23. Schimanski CC, Bahre R, Gockel I, Muller A, Frerichs K, Horner V, Teufel A, Simiantonaki N, Biesterfeld S, Wehler T, Schuler M, Achenbach T, Junginger T, Galle PR, Moehler M (2006) Dissemination of hepatocellular carcinoma is mediated via chemokine receptor CXCR4. Br J Cancer 95: 210-217
24. Sobin LH, Wittekind C (2002) TNM classification of Malignant Tumours, 6th edn. UICC: Wiley-Liss. 81-83
25. Tung-Ping Poon R, Fan ST, Wong J (2000) Risk factors, prevention, and management of postoperative recurrence after resection of hepatocellular carcinoma. Ann Surg 232: 10-24
26. Umetani N, Giuliano AE, Hiramatsu SH, Amersi F, Nakagawa T, Martino S, Hoon DS (2006) Prediction of breast tumor progression by integrity of free circulating DNA in serum. J Clin Oncol 24: 4270-4276
27. Yang Y, Nagano H, Ota H, Morimoto O, Nakamura M, Wada H, Noda T, Damdinsuren B, Marubashi S, Miyamoto A, Takeda Y, Dono K, Umeshita K, Nakamori S, Wakasa K, Sakon M, Monden M (2007) Patterns and clinicopathologic features of extrahepatic recurrence of hepatocellular carcinoma after curative resection. Surgery 141: 196-202
28. Ziegler A, Zangemeister-Wittke U, Stahel RA (2002) Circulating DNA: a new diagnostic gold mine? Cancer Treat Rev 28: 255-271